Investment to support growth initiatives, including near-term add-on 
acquisitions 
 
 
   CHICAGO, Oct. 14, 2025 /PRNewswire/ -- GTCR, a leading private equity 
firm, announced today the simultaneous signing and closing of a 
strategic, structured minority investment in Solmetex (the "Company"). 
Solmetex is a leading provider of dental products, systems, and 
consumables such as amalgam separation, waterline safety solutions, 
dental isolation technology, and regenerative biomaterials. 
 
 
 
   Founded in 1994 as a dental water treatment company focused on the safe 
removal of mercury waste from dental offices, Solmetex now provides 
amalgam separation solutions to over 85,000 dental offices across the 
United States. Through the acquisition and integration of complementary 
products, the Company has expanded its portfolio to include solutions 
for dental waterline treatment and maintenance, modern dental isolation 
solutions and regenerative biomaterials. 
 
 
   GTCR will collaborate with Solmetex's current shareholders, including 
AGIC Capital ("AGIC"), an international private equity firm with 
expertise in healthcare and industrial technology investments spanning 
Europe, Asia, and the United States. GTCR looks forward to working 
alongside Solmetex CEO Gene Dorff, an experienced dental industry 
professional with more than two decades of sector expertise, and the 
Company's management team to drive continued expansion of the Company 
and its service offerings. 
 
 
   The staged investment structure, with potential funding of up to $200 
million, will support the acceleration of Solmetex's expansion strategy 
through both organic growth, leveraging the Company's current product 
portfolio and solutions, as well as through strategic value-enhancing 
acquisitions. 
 
 
   "We are excited to support Solmetex's next phase of growth," said Luke 
Marker, Managing Director. "Solmetex is a high-quality business that is 
uniquely situated in the dental supply chain, and we look forward to 
leveraging our team's investment expertise across the U.S. healthcare 
ecosystem to build upon its strong foundation." 
 
 
   "We are pleased to partner with AGIC through this structured investment, 
" said Jason Prager, Managing Director. "Through flexible capital 
solutions and strategic insights, GTCR supports exceptional management 
teams in executing growth initiatives and driving value creation." 
 
   About Solmetex 
 
 
   Founded in 1994, Solmetex was established as a dental water treatment 
consumables company focused on safely supporting the removal of mercury 
waste from dental offices. Today, the company serves more than 85,000 
dental practices across the U.S., providing trusted solutions for their 
amalgam separation needs. Through a series of strategic acquisitions, 
Solmetex has expanded its portfolio beyond amalgam separation to include 
systems and consumables for dental waterline treatment and testing, 
advanced dental isolation solutions, and regenerative biomaterials. 
These additions have established Solmetex as a comprehensive, trusted 
platform delivering innovative solutions that are relevant to every 
dental practice. For more information, please visit www.solmetex.com. 
 
 
   About GTCR 
 
 
   Founded in 1980, GTCR is a leading private equity firm that invests 
behind The Leaders Strategy(TM) -- finding and partnering with 
management leaders in core domains to identify, acquire and build 
market-leading companies through organic growth and strategic 
acquisitions. GTCR is focused on investing in transformative growth in 
companies in the Business & Consumer Services, Financial Services & 
Technology, Healthcare and Technology, Media & Telecommunications 
sectors. Since its inception, GTCR has invested more than $30 billion in 
approximately 300 companies, and the firm currently manages 
approximately $50 billion in equity capital. GTCR is based in Chicago 
with offices in New York and West Palm Beach. For more information, 
please visit www.gtcr.com. Follow us on LinkedIn. 
 
   About AGIC Capital 
 
 
   AGIC is a growth-oriented private equity firm that invests in thriving 
middle-market businesses focused on advanced industrial and healthcare 
technologies in Europe & beyond. AGIC's differentiated investment 
strategy combines deep business model expertise and proactive thematic 
research with a collaborative, management-first approach to value 
creation. Launched in 2015, AGIC currently has $2.2 billion in assets 
under management. The firm's more than 25 professionals are based in 
Europe and Asia. For more information about AGIC's investment philosophy, 
visit www.agic-group.com. 
 
 
   Media Contacts 
 
 
   For GTCR: 
 
 
   Josh Clarkson / Ryan Smith 
 
 
   212.279.3115 
 
 
   pro-GTCR@Prosek.com 
 
   For AGIC: 
 
 
   contactus@agic-group.com 
 
   For Solmetex: 
 
   Nils Classen 
 
   800.216.5505 (x5634) 
 
 
   nclassen@solmetex.com 
 
 
   View original content to download 
multimedia:https://www.prnewswire.com/news-releases/gtcr-announces-200-million-strategic-minority-investment-in-solmetex-302585007.html 
 
 
 
   SOURCE GTCR 
 
 
 
 
 
 

(END) Dow Jones Newswires

October 15, 2025 10:39 ET (14:39 GMT)